Cytosolic DNA triggers innate immune responses through the activation of cyclic GMP-AMP synthase (cGAS) and production of the cyclic dinucleotide second messenger 2′,3′-cyclic GMP-AMP (cGAMP) 1-4 . 2′,3′-cGAMP is a potent inducer of immune signalling; however, no intracellular nucleases are known to cleave 2′,3′-cGAMP and prevent the activation of the receptor stimulator of interferon genes (STING) 5-7 . Here we develop a biochemical screen to analyse 24 mammalian viruses, and identify poxvirus immune nucleases (poxins) as a family of 2′,3′-cGAMP-degrading enzymes. Poxins cleave 2′,3′-cGAMP to restrict STING-dependent signalling and deletion of the poxin gene (B2R) attenuates vaccinia virus replication in vivo. Crystal structures of vaccinia virus poxin in pre-and post-reactive states define the mechanism of selective 2′,3′-cGAMP degradation through metal-independent cleavage of the 3′-5′ bond, converting 2′,3′-cGAMP into linear Gp[2′-5′]Ap[3′]. Poxins are conserved in mammalian poxviruses. In addition, we identify functional poxin homologues in the genomes of moths and butterflies and the baculoviruses that infect these insects. Baculovirus and insect host poxin homologues retain selective 2′,3′-cGAMP degradation activity, suggesting an ancient role for poxins in cGAS-STING regulation. Our results define poxins as a family of 2′,3′-cGAMP-specific nucleases and demonstrate a mechanism for how viruses evade innate immunity.
the viral factor responsible for 2′,3′-cGAMP degradation poxvirus immune nuclease or poxin.
Poxviruses are large DNA viruses that replicate exclusively in the cytoplasm of infected cells and encode factors dedicated to evasion of host immune signalling 10 . To identify the VACV poxin-encoding gene, we used activity-guided fractionation to specifically enrich poxin from infected cell lysates ( Fig. 1d and Extended Data Fig. 2 ). Massspectrometry analysis of fractions enriched using two independent purification methods revealed that only the protein product of the VACV gene B2R (NCBI YP_233066.1) was highly enriched (Fig. 1e ). Recombinant protein robustly degraded 2′,3′-cGAMP in vitro ( Fig. 1f and Extended Data Fig. 3 ), using the same two-step reaction and broad pH optimum observed with VACV-infected cell lysates, confirming that the VACV B2R gene encodes poxin.
The activity of VACV poxin is specific for 2′,3′-cGAMP; no degradation was observed using chemically related 3′-5′-linked cyclic dinucleotides ( Fig. 2a ). This specificity suggests that poxin is specialized for evasion of DNA sensing by cGAS-STING through degradation of the second messenger 2′,3′-cGAMP. Consistent with this hypothesis, poxin cleavage renders 2′,3′-cGAMP unrecognizable to the receptor STING ( Fig. 2b) and expression of VACV poxin in human cells was sufficient to restrict cGAS-dependent STING activation ( Fig. 2c and Extended Data Fig. 4a, b ). We constructed a mutant virus in which poxin was deleted (VACV ΔPoxin) and confirmed that poxin is necessary for infected cell lysates to degrade 2′,3′-cGAMP (Extended Data Fig. 4g ). cGAS has previously been shown to be a critical factor for restriction of poxvirus replication [11] [12] [13] [14] . To assess the effect of poxin deletion on VACV fitness in vivo, we next infected mice by scarification and measured viral loads in the resulting skin lesions. Although poxin is dispensable for replication in interferon-deficient cells (Extended Data Fig. 4h ), VACV ΔPoxin replication in mice is more than 40-fold attenuated compared to wild-type VACV (Fig. 2d ), demonstrating the importance of poxin function in vivo. No increase in interferon-β (IFNβ) signalling was observed during VACV ΔPoxin infection in an interferon-competent cell culture model of replication (Extended Data Fig. 4i ), indicating that the key function of poxin in vivo may relate to spread of 2′,3′-cGAMP rather than prevention of interferon signalling in the primary infected cell. Together, these data describe a mechanism in which poxin-mediated cleavage of 2′,3′-cGAMP allows viral evasion of cGAS-STING immunity.
To define the molecular mechanism of poxin activity, we determined a series of X-ray crystal structures of VACV poxin that correspond to the apo (1.7 Å), pre-reactive (2.6 Å) and post-reactive (2.1 Å) states of 2′,3′-cGAMP degradation (Extended Data Table 1 ). VACV poxin forms a V-shaped homodimeric complex, in which N-terminal protease-like domains flank a central 14-stranded β-sandwich core created by extensive hydrophobic contacts between the C-terminal domains of each monomer ( Fig. 3a and Extended Data Fig. 5 ). The pre-reactive crystal structure of VACV poxin bound to a phosphorothioate nonhydrolysable 2′,3′-cGAMP analogue reveals that substrate recognition Letter reSeArCH occurs in a deep pocket between the N-terminal and C-terminal domains of opposing monomers. Helix σ2 in the C-terminal domain undergoes movement of 4 Å to clamp around the captured 2′,3′-cGAMP molecule (Extended Data Fig. 5b ). Eight poxin residues read out the base identity and unique geometry imposed by the non-canonical 2′-5′ bond, explaining the specificity of 2′,3′-cGAMP recognition ( Fig. 3b and Extended Data Fig. 6 ).
The 2′-5′ bond of 2′,3′-cGAMP is buried in a deep pocket and the 3′-5′ bond is presented in the poxin active site for hydrolysis ( Fig. 3b ). Using site-specific labelling of 2′,3′-cGAMP, we confirmed that degradation occurs through specific hydrolysis of the canonical 3′-5′ bond, leaving the 2′-5′ bond intact (Extended Data Fig. 7a, b ). Crystals of poxin that were grown in the presence of 2′,3′-cGAMP yielded a post-reactive structure and clear density for the final product Gp[2′-5′] Ap[3′] (Extended Data Fig. 6 ). Notably, metal ions were not observed in these structures and poxin activity is resistant to metal chelation (Extended Data Fig. 7c ). Once bound to poxin, the adenine base in 2′,3′-cGAMP is rotated 60° compared to the in-solution or STINGbound conformation 15-18 , resulting in a distorted 2′,3′-cGAMP conformation that repositions the 2′-OH to serve as the reactive nucleophile ( Fig. 3c ). VACV poxin residues H17, Y138 and K142 are located proximal to the scissile 3′-5′ bond, and positioning in the active site suggests that H17 and K142 function as the general acid and base of the reaction (Fig. 3b, d ). Mutational analysis confirmed H17 and K142 are essential for activity, whereas mutation of Y138 stalls the reaction at the intermediate stage ( Fig. 3e) . A similar catalytic triad is observed in tRNA-splicing endonucleases 19 (Extended Data Fig. 6c ), supporting that poxin-catalysed degradation of 2′,3′-cGAMP proceeds through the conventional reaction shared between metal-independent 
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3′,3′-CDN ribonucleases 20 . In summary, these data reveal the mechanism by which poxin, a metal-independent nuclease, cleaves the canonical bond of 2′,3′-cGAMP to inhibit cGAS-STING signalling. VACV poxin does not exhibit any detectable structural homology with previously described nuclease or phosphodiesterase enzymes. Poxin is conserved in most viruses in the genus Orthopoxvirus, including the human pathogens monkeypox virus and cowpox virus ( Fig. 4a and Extended Data Figs. 8a, 9a), and is sometimes fused to an additional C-terminal domain previously noted to have homology with human schlafen proteins 21 . We cloned four divergent poxin genes from members of the Poxviridae and each retained specific recognition of 2′,3′-cGAMP and hydrolysis activity ( Fig. 4b and Extended Data Fig. 9c ). We next used the structure of VACV poxin and conservation of active-site residues to guide a bioinformatics search for divergent poxin family members outside of the Poxviridae. Notably, this search revealed poxin homologues in the Alphabaculovirus genus of insect DNA viruses (p26 proteins, for example, AcNPV p26 (NCBI NP_054166.1)) and poxin genes in insects of the order Lepidoptera, which serve as exclusive hosts of alphabaculoviruses (HDD13 proteins, for example, Bombyx mori HDD13 (NCBI XP_021205460.1)) ( Fig. 4c ). Insect cellular and viral poxin homologues are enzymatically active, retain specificity for 2′,3′-cGAMP degradation, and insect host poxin activity can be detected in lysates of the insect cell lines Sf21 and Hi5 (Fig. 4d , e and Extended Data Fig. 9c ). In support of a conserved role of insect poxins in immune regulation, the STING signalling pathway is functional in insects 18,22,23 and the lepidopteran poxin gene is induced upon pathogen infection 24 . Poxviruses and baculoviruses can share overlapping host tropisms and readily acquire genes through homologous recombination 25,26 , potentially explaining how poxins evolved and spread between insects, insect viruses and mammalian pathogens ( Fig. 4f ).
Through discovery and characterization of a 2′,3′-cGAMP-specific nuclease in VACV-infected cell lysates, our data reveal a potent viral strategy for cGAS-STING pathway evasion. Poxin activity provides a mechanistic explanation for recent findings that have shown that virulent poxviruses inhibit cGAS-STING signalling during infection at a step downstream of cGAS activation 13 . Two notable exceptions to conservation of poxin activity are Variola major virus, the causative Letter reSeArCH agent of smallpox disease, and the modified vaccinia Ankara (MVA) vaccine strain, which both show inactivation of poxin ( Fig. 4a and Extended Data Fig. 8b ). Inactivation of the poxin gene in Variola major virus further suggests that multiple strategies may exist in poxviruses to subvert cGAS-STING immunity 27 . Poxvirus vectors are widely used in human and animal vaccination, gene therapy and as cancer oncolytics 28,29 . Loss of poxin resulted in significant attenuation of VACV in a mouse model of replication, indicating that modulation of cGAS-STING signalling through poxin deletion may be an important consideration in the design of poxvirus-based vaccines and therapeutics. The ability of 2′,3′-cGAMP to cross cellular gap junctions 5 and infiltrate budding viral particles 8,9 provides the host an opportunity to counteract pathogen factors that inhibit cGAS-STING activation but that do not completely eliminate all 2′,3′-cGAMP production 30 . Through direct targeting of 2′,3′-cGAMP, poxin activity is a viral adaptation to prevent both activation and cellular spread of STING signalling. Conservation of poxins between mammalian viruses and insects reaffirms the ancestral roots of 2′,3′-cGAMP-dependent signalling in animals 18 , and underscores the wide range of host-virus conflicts that drive new mechanisms of innate immune surveillance and evasion.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-019-0928-6. Letter reSeArCH METHODS Cell lines and viruses. A549, BSC-40, BSR-T7 and Vero cells, as well as VACV (strain western reserve vTF7-3) 31 stocks were gifts from S. Whelan (Harvard Medical School). THP-1 cells and HEK293T cells were purchased from ATCC. All cell lines were maintained in Dulbecco's modified Eagle medium (DMEM) (VWR) supplemented with 10% fetal bovine serum (FBS) (VWR, Seradigm), with the exception of THP-1 cells, which were maintained in RPMI-1640 medium (Life Technologies) supplemented with 10% FBS and 50 nM β-mercaptoethanol. Cell lines used were not authenticated and were not tested for mycoplasma contamination. Infections with VACV were performed for 1 h in 1× PBS supplemented with 1 mM CaCl 2 and 1 mM MgCl 2 . After 1 h, excess virus was aspirated, and cells were either collected (at 1 h after infection) or the infection was allowed to continue in DMEM supplemented with 2.5% FBS and 50 mM HEPES-NaOH pH 7.5 until collection at stated time points. Infected cells were washed once in 1× PBS, scraped into 1× PBS, collected by centrifugation and lysed in 1% NP-40, 20 mM HEPES-NaOH pH 7.5, 150 mM NaCl, 1 mM TCEP-KOH to prepare virus-infected cell lysates. Infections with other viruses were performed according to details in Supplementary Table 1 . Sf21 and Hi5 insect cells were gifts from R. Ross and S. Harrison (Harvard Medical School). Spinner cultures of insect cells were maintained in TC100 medium (Gibco) supplemented with 10% FBS, and cells were collected by centrifugation and lysed with the same lysis buffer as above. VACV was propagated in Vero cells and plaque assays were performed in Vero cells according to published protocols 32 . Synthesis of cyclic dinucleotides. 2′,3′-cGAMP for downstream degradation assays was produced using recombinant mouse cGAS. Recombinant human SUMO2-tagged mouse cGAS was purified from E. coli using Ni-NTA affinity, digested with human SENP2 protease and further purified with heparin ion-exchange and S75 size-exclusion chromatography as previously described 33 Fig. 7a , for which the indicated reactions were labelled with [α 32 P]ATP. After completion, reactions were treated with Antarctic Phosphatase (NEB) for 20 min to digest the remaining labelled nucleoside triphosphates and heat-inactivated at 65 °C for 20 min before direct use in downstream poxin activity assays. 3′-5′-linked cyclic dinucleotides were enzymatically synthesized in a similar manner using recombinant Vibrio cholerae DncV incubated with either ATP and GTP (3′,3′-cGAMP synthesis), GTP alone (c-di-GMP synthesis), or ATP alone (c-di-AMP synthesis) as previously described 18, 34 . All 3′-5′-linked cyclic dinucleotides were prepared with 200 μM of each required nucleoside triphosphate, except for experiments in Extended Data Fig. 9c , for which synthesis was performed with 25 μM of each nucleoside triphosphate.
2′,3′-cGAMP used for crystallography was enzymatically synthesized by 24 h incubation at 37 °C of 100 nM recombinant mouse cGAS with 500 μM each ATP and GTP in the presence of 50 μg ml −1 salmon sperm DNA in 500 ml buffer composed of 10 mM Tris-HCl pH 7.5, 12.5 mM NaCl, 10 mM MgCl 2 and 1 mM DTT. 2′,3′-cGAMP was subsequently purified by IEX (2 × 5 ml HiTrap Q columns) on a gradient of 0-2 M NH 4 OAc and lyophilized. Freeze-dried 2′,3′-cGAMP was washed twice with methanol before final lyophilization and storage as powder at −20 °C. For the virus lysate screen in Fig. 1b , around 30 ng of total protein normalized by Bradford assay of each virus-infected cell lysate was incubated in a 10-μl reaction with approximately 2.5 μM 2′,3′-cGAMP for 20 h at 37 °C. In all further experiments with VACV-infected cell lysates, 100 ng VACV-infected cell lysate was used in each reaction. In experiments with Sf21 and Hi5 lepidopteran cell lysates, 1 μg lysate was used in each reaction. Recombinant poxin protein-activity assays were carried out at a final concentration of 100-400 nM poxin. Unless otherwise stated, reactions were carried out for 5-15 min before resolution of degradation products on a PEI-cellulose thin-layer chromatography (TLC) plate (Millipore) in a solvent composed of 1.5 M KH 2 PO 4 pH 3.8. After developing, TLC plates were dried and exposed to a phosphor screen overnight and imaged on a Typhoon phosphor-imager (GE). Virus lysate screen. Infections with diverse viruses were carried out by collaborating laboratories according to the conditions listed in Supplementary Table 1 . Infected cells were collected and stored at −80 °C before lysis in 1% NP-40, 20 mM HEPES-KOH pH 7.5, 150 mM NaCl and 1 mM TCEP-KOH. Cytoplasmic extracts were generated by collecting the supernatant fraction following centrifugation of whole-cell lysates at 22,000g for 10 min. Lysate concentrations were quantified using a Bradford assay and normalized accordingly before poxin activity assays as described above. Poxin biochemical fractionation and identification. Poxin was enriched and identified directly from infected cell lysates. In brief, 16 T150 flasks of BSC-40 cells were infected at an MOI of 5. After 6 h, cells were scraped into 1× PBS, collected by centrifugation and stored at −80 °C. The resulting infected material was split into two portions, lysed and fractionated with either IEX-based or a HICbased purification methods. Cells were lysed in 1% NP-40, 20 mM HEPES-KOH pH 7.5, 150 mM NaCl, 1 mM DTT and cytosolic lysates were collected from the supernatant fractions following centrifugation at 22,000g for 10 min. Resulting cytoplasmic extracts were fractionated by IEX using a 1-ml HiTrap Q HP column and a gradient from 0.05 to 1 M NaCl. Fractions with poxin activity were pooled and further purified on a 10/300 S200 size-exclusion column (GE). Alternatively, cytoplasmic extracts were subjected to a 30% (NH 4 ) 2 SO 4 cut at 4 °C for 1 h with gentle spinning, and centrifuged at 50,000g for 15 min. Clarified supernatant was loaded on a 1-ml HiTrap Phenyl HIC column (GE), and eluted using a gradient of 1.2-0 M (NH 4 ) 2 SO 4 in a buffer containing constant 150 mM NaCl. Enriched fractions with poxin activity were then further fractionated on a 10/300 S75 size exclusion column (GE). After each purification step, 1 μl of each fraction was tested for poxin activity as described above, and active fractions were pooled for additional purification. After IEX and size exclusion, the single fraction with peak activity and inactive background fractions that eluted before and after poxin activity were analysed by mass spectrometry. Additionally, a single active fraction was selected for analysis after HIC and size exclusion. Mass spectrometry protein analysis and label-free quantification of the IEX samples were performed at the Harvard Medical School Taplin Facility. Recombinant protein purification. The VACV poxin gene B2R was PCRamplified from purified viral DNA and cloned into a custom pET vector designed to express a 6 × His-tagged N-terminal human SUMO2 fusion 33 . Poxin homologues were cloned using synthetic DNA fragments (IDT) and HiFi Gibson assembly (NEB). Recombinant poxin proteins were expressed in E. coli BL21 RIL bacteria (Agilent) using 50 ml starter cultures grown in MDG medium and two 1-litre induction cultures grown in M9ZB medium as previously described 33 . Alternatively, MPXV poxin starter and induction cultures were grown with 2YT medium as previously described 34 . VACV poxin with a selenomethionine (SeMet) substitution was grown in overnight MDG starter cultures, and in two 1-litre induction cultures of altered M9ZB medium containing 40% glucose as a sole carbon source, supplemented with 1 μg ml −1 thiamine. SeMet M9ZB cultures were grown to an optical density at 600 nm (OD 600 nm ) of around 0.6 before addition of the following amino acids for SeMet labelling and suppression of methionine biosynthesis: 50 mg l −1 leucine, isoleucine and valine (VWR); 100 mg l −1 phenylalanine, lysine and threonine (VWR); 75 mg l −1 selenomethionine (Acros Organics). Cultures were allowed to grow for an additional 20 min at 37 °C with shaking at 230 r.p.m. and were then transferred to an ice bath for 20 min. Cultures were then supplemented with 0.5 mM IPTG and incubated at 16 °C with shaking at 230 r.p.m. for overnight growth. Collected cells were disrupted by sonication in lysis buffer (20 mM HEPES-KOH pH 7.5, 400 mM NaCl, 30 mM imidazole, 10% glycerol and 1 mM DTT), and poxin proteins were purified from clarified lysates at 4 °C using Ni-NTA resin (Qiagen) and gravity chromatography. Ni-NTA resin was washed with lysis buffer adjusted to a higher 1 M NaCl concentration and eluted with lysis buffer adjusted to a higher 300 mM imidazole concentration. The elution fraction was supplemented with approximately 250 μg of human SENP2 protease (fragment D364-L589 with M497A mutation) 35 and dialysed overnight at 4 °C in dialysis buffer (20 mM HEPES-KOH pH 7.5, 300 mM NaCl and 1 mM DTT). Untagged poxin was further purified using 16/600 S75 size-exclusion chromatography (GE) in 20 mM HEPES-KOH pH 7.5, 250 mM KCl and 1 mM TCEP-KOH. Final protein was concentrated to around 10-35 mg ml −1 , flash-frozen in liquid nitrogen and stored at −80 °C for crystallography. Alternatively, proteins for biochemistry analysis were supplemented with 10% glycerol before −80 °C storage. Poxin mutants tested in Fig. 3 and poxin homologues tested in Fig. 4 and Extended Data Fig. 9 were purified as SUMO2 fusions, and dialysed directly into storage buffer without SENP2 digestion. STING electrophoretic mobility shift assay. Human STING-cyclic dinucleotide electrophoretic mobility shift assays were performed as previously described 18 . In brief, around 500 nM of 32 P radiolabelled 2′,3′-cGAMP or poxin-treated 2′,3′-cGAMP was incubated in a 10-μl reaction with around 20 μM human STING N154-V341 (wild-type R232) in 1× reaction buffer (50 mM Tris-HCl pH 7.5, 5 mM Mg(OAc) 2 , 70 mM KCl and 1 mM TCEP-KOH) for 30 min at 25 °C. Reactions were supplemented with loading dye (6×: 40% sucrose and 0.05% xylene cyanol) and separated on a 6% non-denaturing polyacrylamide gel (7.2 cm tall, prepared with 29:1 acrylamide:bis-acrylamide and 0.5× TBE buffer) run at 100 V for 45 min with 0.5× TBE running buffer. The gel was incubated in fixing reagent (10% acetic acid and 40% methanol) for 30 min and then dried at 80 °C before exposure to a phosphor screen and imaging on a Typhoon phosphor-imager (GE). Poxin stable cell lines and cell-based IFNβ reporter assays. Haemagglutinintagged wild-type VACV poxin and a catalytically inactive VACV poxin mutant H17A were cloned into the lentiviral transduction vector pN103 36 . Lentivirus was prepared as previously described 36 and lentivirally transduced HEK293T cells were selected with 1 μg ml −1 puromycin for two passages before removal of selection. Luciferase assays were performed as previously described 37 . In brief, HEK293T cells expressing poxin(WT) or poxin(H17A) were transfected with Lipofectamine 2000 in 96-well plates with: a control pRL plasmid encoding Renilla luciferase under a constitutive promoter (2 ng), a pIFNβ FLuc reporter plasmid encoding firefly luciferase under the IFNβ promoter (20 ng), a pcDNA4 plasmid encoding human STING wild-type allele R232 (10 ng), and either an empty vector or a pcDNA4 plasmid encoding full length human cGAS (1 ng). Luciferase activity was quantified after 18 h and firefly luciferase activity was normalized to the Renilla luciferase control. Fold reporter induction was calculated by dividing the luciferase activity observed with human cGAS by background activity observed with the empty vector transfection. Selection and validation of poxin knockout virus. Selection of poxin knockout virus was performed as previously described 38 . A cassette encoding the super-folding GFP (sfGFP) gene 39 flanked by 250-bp homology arms identical to the VACV genome upstream and downstream of B2R was cloned into a pcDNA4 vector. The cassette was amplified by PCR to create linear homologous recombination template DNA. BSR-T7 cells in six-well dishes were infected at MOI 0.05 with VACV (strain Western Reserve vTF7-3) as above, and after 1 h virus binding, the inoculum was aspirated and replaced with DMEM supplemented with 2.5% FBS, before immediate transfection with 2 μg of linear homologous recombination template. After 48 h, cells were scraped into medium, collected by centrifugation, resuspended in DMEM with 2.5% FBS and lysed by three freeze-thaw cycles, vortexing and sonication. The resulting stock was plaque-purified on Vero cells by coring sfGFP-positive plaques and transferring them into DMEM with 2.5% FBS. VACV ΔPoxin virus was purified through three iterative rounds of sfGFP-positive plaque purification, before viral stocks were prepared for use in downstream experiments. Viral stocks were used as PCR template as previously described 40 , and amplicons encompassing the entire poxin B2R locus extending through homologous recombination junctions were verified by Sanger sequencing (Extended Data Fig. 4e ).
Measurement of virus interferon induction by qRT-PCR. A549 cells were
infected at an MOI of 5 with wild-type VACV or VACV ΔPoxin and lysed 5 h after infection. As a positive control, cells were permeabilized for 30 min with digitonin buffer (10 μg ml −1 digitonin, 50 mM HEPES-KOH pH 7.5, 100 mM KCl, 3 mM MgCl 2 , 0.1 mM DTT, 85 mM sucrose, 0.2% BSA, 1 mM ATP and 0.1 mM GTP) and stimulated with or without 25 μM 2′,3′-cGAMP as previously described 41 . After stimulation, the cells were washed once with DMEM supplemented with 10% FBS, the medium was replaced and cells were incubated for 5 h before lysis. Infected or stimulated cells were lysed directly in TRIzol reagent (Life Technologies) and RNA was extracted according to the manufacturer's instructions. Reverse transcription was carried out in a buffer composed of 25 mM Tris-HCl pH 8.4, 37.5 mM KCl and 1.5 mM MgCl 2 using MMLV-M5 reverse transcriptase 42 . qPCR was performed using LUNA qPCR mix (New England Biolabs) according to the manufacturer's instructions, with a final concentration of 500 nM each forward and reverse primers. Quantification was performed using the ΔΔC t method, normalizing to GAPDH. Primers were as follows: GAPDH: (forward) 5′-TTCGACAGTCAGCCGCATCTTCTT-3′ and (reverse) 5′-CAGGCGCCCAATACGACCAAATC-3′, IFNB1: (forward) 5′-CA GCAGTTCCAGAAGGAGGA-3′ and (reverse) 5′-AGCCAGGAGGTTCTC AACAA-3′, CXCL10: (forward) 5′-CCAGAATCGAAGGCCATCAA-3′ and (reverse) 5′-CCTTTCCTTGCTAACTGCTTTCAG-3′. In vivo VACV replication and determination of tissue viral load. Wild-type C57BL/6 mice were purchased from the Jackson Laboratory and maintained through routine breeding in the animal facility of Harvard Institutes of Medicine, Harvard Medical School. Animal experiments were performed in accordance with the guidelines put forth by the Center for Animal Resources and Comparative Medicine at Harvard Medical School, and all protocols and experimental plans received prior approval from the HMS IACUC. Mice were randomly assigned to each group before start. Experimental groups of 7-week-old female mice (n = 5 mice per group) were infected with either wild-type VACV or VACV ΔPoxin. The sample size was chosen based on a previously published protocol to ensure sufficient statistical power 43, 44 . Mice were infected by skin scarification with 1 × 10 6 plaque-forming units, then at 8 days after viral infection, VACV load was evaluated by qRT-PCR as described previously 43, 44 . In brief, inoculated skin samples were collected and DNA was purified with the DNeasy Mini kit (Qiagen) according to the manufacturer's protocol. qPCR was performed with the Bio-Rad iCycler iQ Real-Time PCR Detection System (Bio-Rad Laboratories). The primers and TaqMan probe used in the quantitative PCR assay are specific for the ribonucleotide reductase I4L. The sequences are (forward) 5′-GACACTCTGGCAGCCGAAAT-3′; (reverse) 5′-CTGGCGGCTAGAATGGCATA-3′; (probe) 5′-AGCAGCCAC TTGTACTACACAACATCCGGA-3′. The probe was 5′-labelled with FAM and 3′-labelled with TAMRA (Applied Biosystems). Amplification reactions were performed in a 96-well PCR plate (Bio-Rad) in a 20-μl volume containing 2× TaqMan Master Mix (Applied Biosystems), 500 nM forward primer, 500 nM reverse primer, 150 nM probe and the template DNA. Thermal cycling conditions were 50 °C for 2 min and 95 °C for 10 min for one cycle, followed by 45 cycles of amplification (94 °C for 15 s and 60 °C for 1 min). To calculate the viral load, a standard curve was established from DNA of a VACV stock with previously determined titre. Corresponding C t values obtained by the qPCR method were plotted on the standard curve to estimate viral load in the skin samples. Comparisons for two groups were calculated using two-tailed Student's t-test. Blinding was not performed during data collection or analysis, as results were based on quantitative assessment of viral load. Crystallization and structure determination. VACV poxin crystals were grown by hanging-drop vapour diffusion at 18 °C. SeMet-labelled VACV poxin was crystallized in apo form and native VACV poxin crystals were grown in complex with the phosphorothioate non-hydrolysable analogue of 2′,3′-cGAMP (c[G(2′,5′) pS(R)-A(3′,5′)pS(S)], stereoisomer 1) (Biolog) yielding a pre-reactive structure or in complex with native 2′,3′-cGAMP, yielding a post-reactive structure. SeMetsubstituted apo VACV poxin crystals grew in 100 mM HEPES-NaOH pH 7.0, 20-22% PEG-2000 MME and cryoprotected by the addition of 20% ethylene glycol. Native VACV poxin crystals were grown with 300 μM non-hydrolysable 2′,3′-cGAMP or with 3.3 mg ml −1 purified 2′,3′-cGAMP in 100 mM NaOAc pH 4.8, 10-11% PEG-20000 and cryoprotected by the addition of 30% ethylene glycol. X-ray diffraction data were collected at the Advanced Light Source (beamline 8.2.1) and the Advanced Photon Source (beamline 24-ID-C).
X-ray crystallography data were processed with XDS and AIMLESS 45 using the SSRL autoxds script (A. Gonzalez, Stanford SSRL). Experimental phase information for VACV poxin was determined using data collected from SeMet-substituted crystals. In total, 35 sites were identified with HySS in PHENIX 46 and an initial map was produced using SOLVE/RESOLVE 47 . Model building was performed using Coot 48 , before refinement in PHENIX. The 1.7 Å SeMet apo VACV poxin structure was subsequently used as a molecular replacement search model for determination of pre-reactive and post-reactive native VACV poxin structures. Final structures were refined to stereochemistry statistics for Ramachandran plot (favoured/allowed), rotamer outliers and MolProbity score as follows: VACV poxin apo, 97.65%/2.35%, 0.15% and 1.23; VACV Poxin pre-reactive state, 96.14%/3.7%, 1.15% and 1.58; VACV poxin post-reactive state 97.93%/2.07%, 0.72% and 1.15. Bioinformatics and poxin homologue identification. Position-specific iterative BLAST (PSI-BLAST) search was used to identify homologues of VACV poxin, using default settings (BLOSUM62 matrix, Gap Costs: Existence 11, Extension 1, conditional compositional score matrix adjustment). All significant (E value less than 0.05) sequences that contained the known VACV poxin active site and key structural residues were selected after each PSI-BLAST round (up to 500) for refinement of the substitution matrix in each additional PSI-BLAST round. After a single PSI-BLAST round, poxvirus sequences were identified. Refinement of the substitution matrix by a further round (2 total rounds) allowed identification of baculovirus p26 proteins, and a third round identified lepidopteran host HDD13 proteins as homologues of VACV poxin. Using alignments to VACV poxin and the crystal structure, full-length homologue sequences possessing putative catalytic residues were selected for recombinant production and biochemical poxin activity assays. Statistics and reproducibility. Most biochemistry experiments are representative of at least three independent experiments, with select experiments representative of two independent experiments: virus lysate screen (Fig. 1b) , poxin fractionation and mass-spectrometry analysis (Fig. 1d, e ), STING gel-shift interactions (Fig. 2b) , PCR validation of VACV ΔPoxin (Extended Data Fig. 4d ), VACV ΔPoxin growth curves (Extended Data Fig. 4h ) and VACV ΔPoxin interferon qRT-PCR experiments (Extended Data Fig. 4i ). Mice scarification experiments were performed with a sample size previously determined to ensure sufficient statistical power 43, 44 . All other experimental replicate details are listed in the extended data figure legends. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Data Availability
Coordinates and structure factors of the VACV Poxin apo and Poxin-2′,3′-cGAMP complexes have been deposited in Protein Data Bank (PDB) under accession codes 6EA6, 6EA8 and 6EA9. All other data are available in the manuscript or the supplementary materials. Fig. 4 | Construction and validation of poxin-expressing cells and poxin knockout virus. a, TLC analysis of lysates from HEK293T cells after transduction with poxin(WT) or the poxin(H17A) catalytically inactive construct, and selection with puromycin. HEK293T poxin(WT) cells but not control cells show degradation of 2′,3′-cGAMP after a 1-h reaction. Data are representative of two independent experiments. The '−' refers to a buffer-only control. b, Western blot analysis of poxin-transduced cell lines demonstrating expression of both VACV poxin(WT) and poxin(H17A) proteins. Data are representative of two independent experiments. Gel source data are available in Supplementary  Fig. 1. c Vero cells infected with wild-type VACV poxin or VACV ΔPoxin after 20 h at MOI = 1. VACV ΔPoxin-infected cells express sfGFP. Data are representative of three independent experiments. g, TLC analysis of 2′,3′-cGAMP after incubation with lysates of cells infected with wild-type or ΔPoxin viruses. VACV ΔPoxin-infected cells lack detectable 2′,3′-cGAMP degradation activity. The '−' refers to a buffer-only control; M refers to a mock-infection control. Data are representative of three independent experiments. h, Multiple cycle growth curve (MOI = 0.01) of wildtype and ΔPoxin VACV strains in Vero cells, demonstrating that poxin knockout has no effect on viral growth kinetics in interferon-deficient cells in cell culture (n = 2). Data are mean ± s.e.m. i, qRT-PCR analysis of the transcriptional induction of IFNβ and an interferon-stimulated gene (CXCL10) following infection of A549 cells with wild-type or ΔPoxin VACV after 5 h at MOI = 5 (n = 2). Poxin deletion does not increase IFNβ-dependent signalling in cell culture under these conditions. As a positive control, STING-dependent signalling in A549 cells was stimulated with 2′,3′-cGAMP and digitonin permeabilization.
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Extended Data Fig. 5 | Structural analysis of VACV poxin. a, VACV poxin consists of two domains and homodimerizes to form the active complex. The N-terminal domain (green) has structural homology to viral 3C-like proteases (r.m.s.d. of 2.9 Å). The norovirus NS6 protease and Bos taurus trypsin protease are coloured in green and presented in the same orientation for comparison 49, 50 . Z-scores were obtained from the DALI server 51 . The C-terminal domain (cyan) of VACV poxin has no known structural homologues. b, Overlay of the apo (red) and 2′,3′-cGAMP bound pre-reactive (green/cyan/grey) poxin structures. 2′,3′-cGAMP binding induces a 4 Å movement of the clamp helix and repositions the active site for 3′-5′-bond hydrolysis. c, VACV poxin dimerization is mediated by antiparallel β-strand hydrogen bonding between monomers, as well as side-chain interactions within a hydrophobic core composed of M183, M185 and F187.
Extended Data Fig. 9 | Conservation of poxin family members and 2′,3′-cGAMP-specific nuclease activity in Poxviridae, Baculoviridae and host Lepidoptera. a, Phylogenetic conservation of poxin family members in Poxviridae, Baculoviridae and host Lepidoptera genomes. Poxin catalytic residues (red) and 2′,3′-cGAMP-interacting residues (black) are indicated on the right, shaded in blue according to conservation, and listed according to VACV poxin amino acid number (Poxviridae, top) or AcNPV poxin amino acid number (Baculoviridae, middle). The metazoan poxin sequences from moth and butterfly genomes (Lepidoptera, bottom) share homology throughout the entire poxin protein and exhibit identical 2′,3′-cGAMP degradation activity, but the alignment with viral poxins does not allow definitive assignment of the catalytic residues. Phylogram schematics are based on previous analyses [52] [53] [54] [55] . b, Coomassie-stained SDS-PAGE analysis of recombinant SUMO2-tagged poxin homologue proteins. c, TLC analysis of recombinant viral and host cellular poxin activity after 20 h incubation with substrates. All viral and metazoan poxin family members are specific 2′,3′-cGAMP nucleases. No activity is detected using the chemically related cyclic dinucleotide 3′,3′-cGAMP. The '−' refers to a buffer-only control. Data are representative of three independent experiments. All datasets were collected from individual crystals. Values in parentheses are for the highest resolution shell.
